Editorial: Women in onconephrology: 2022

por Abudayyeh, Ala, Karam, Sabine
Publicado 2023

Does treating with anti–PD-1 to improve glomerular health come without a cost?

por Jhaveri, Kenar D., Kitchlu, Abhijat, Abudayyeh, Ala
Publicado 2022

RNAi and cancer: Implications and applications

por Abdelrahim, Maen, Safe, Stephen, Baker, Cheryl, Abudayyeh, Ala
Publicado 2006

Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates

por Kawashima, Shun, Joachim, Kole, Abdelrahim, Maen, Abudayyeh, Ala, Jhaveri, Kenar D., Murakami, Naoka
Publicado 2022

Pathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor–Induced Kidney Injury

por Abudayyeh, Ala, Suo, Liye, Lin, Heather, Mamlouk, Omar, Abdel-Wahab, Noha, Tchakarov, Amanda
Publicado 2022

Membranous nephropathy in autologous hematopoietic stem cell transplant: autologous graft-versus-host disease or autoimmunity induction?

por Abudayyeh, Ala, Truong, Luan D., Beck, Laurence H., Weber, Donna M., Rezvani, Katy, Abdelrahim, Maen
Publicado 2015

Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib

por Rajasekaran, Arun, Ngo, Thuy-Trang, Abdelrahim, Maen, Glass, William, Podoll, Amber, Verstovsek, Srdan, Abudayyeh, Ala
Publicado 2015

Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report

por Abdelrahim, Maen, Esmail, Abdullah, Umoru, Godsfavour, Westhart, Kiersten, Abudayyeh, Ala, Saharia, Ashish, Ghobrial, Rafik M.
Publicado 2022

Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma

por Hedrick, Erik, Lee, Syng-Ook, Kim, Gyungeun, Abdelrahim, Maen, Jin, Un-Ho, Safe, Stephen, Abudayyeh, Ala
Publicado 2015

Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab

por Lin, Jamie S, Wang, Daniel Y, Mamlouk, Omar, Glass, William F, Abdelrahim, Maen, Yee, Cassian, Abudayyeh, Ala
Publicado 2020

Checkpoint inhibitor-related renal vasculitis and use of rituximab

por Mamlouk, Omar, Lin, Jamie S, Abdelrahim, Maen, Tchakarov, Amanda S, Glass, William F, Selamet, Umut, Buni, Maryam, Abdel-Wahab, Noha, Abudayyeh, Ala
Publicado 2020

Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening

por Badheeb, Mohamed, Abdelrahim, Adham, Esmail, Abdullah, Umoru, Godsfavour, Abboud, Karen, Al-Najjar, Ebtesam, Rasheed, Ghaith, Alkhulaifawi, Mohammed, Abudayyeh, Ala, Abdelrahim, Maen
Publicado 2022

Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response

por Parvathareddy, Vishnupriyadevi, Selamet, Umut, Sen, Aditi A., Mamlouk, Omar, Song, Juhee, Page, Valda D., Abdelrahim, Maen, Diab, Adi, Abdel-Wahab, Noha, Abudayyeh, Ala
Publicado 2023

Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab

por Qureshi, Sehrish, Arani, Naszrin, Parvathareddy, Vishnu, Tchakarov, Amanda, Abdelrahim, Maen, Suarez-Almazor, Maria, Zhang, Jianjun, Gibbons, Don Lynn, Heymach, John, Altan, Mehmet, Abudayyeh, Ala
Publicado 2023

Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

por Abdelrahim, Maen, Mamlouk, Omar, Lin, Heather, Lin, Jamie, Page, Valda, Abdel-Wahab, Noha, Swan, Joshua, Selamet, Umut, Yee, Cassian, Diab, Adi, Suki, Wadi, Abudayyeh, Ala
Publicado 2021

Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Exp...

por Abdelrahim, Maen, Esmail, Abdullah, Xu, Jiaqiong, Umoru, Godsfavour, Al-Rawi, Hadeel, Saharia, Ashish, Abudayyeh, Ala, Victor, David, McMillan, Robert, Kodali, Sudha, Ghobrial, Rafik M.
Publicado 2022

Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View

por Abdelrahim, Maen, Esmail, Abdullah, Saharia, Ashish, Abudayyeh, Ala, Abdel-Wahab, Noha, Diab, Adi, Murakami, Naoka, Kaseb, Ahmed O., Chang, Jenny C., Gaber, Ahmed Osama, Ghobrial, Rafik Mark
Publicado 2022

Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology

por Abboud, Karen, Umoru, Godsfavour, Esmail, Abdullah, Abudayyeh, Ala, Murakami, Naoka, Al-Shamsi, Humaid O., Javle, Milind, Saharia, Ashish, Connor, Ashton A., Kodali, Sudha, Ghobrial, Rafik M., Abdelrahim, Maen
Publicado 2023

Infliximab for the treatment of patients with checkpoint inhibitor–associated acute tubular interstitial nephritis

por Lin, Jamie S., Mamlouk, Omar, Selamet, Umut, Tchakarov, Amanda, Glass, William F., Sheth, Rahul A., Layman, Rachel M., Dadu, Ramona, Abdelwahab, Noha, Abdelrahim, Maen, Diab, Adi, Yee, Cassian, Abudayyeh, Ala
Publicado 2021

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

por Abdel-Wahab, Noha, Safa, Houssein, Abudayyeh, Ala, Johnson, Daniel H., Trinh, Van Anh, Zobniw, Chrystia M., Lin, Heather, Wong, Michael K., Abdelrahim, Maen, Gaber, A. Osama, Suarez-Almazor, Maria E., Diab, Adi
Publicado 2019